tiprankstipranks
Trending News
More News >
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Revenue

Compare
918 Followers

Intra-Cellular Therapies Revenue

Intra-Cellular Therapies had a revenue of 199.22M in the quarter ending Dec 31, 2024, with 13.74%. This bring the company's revenue in the last twelve months to 680.64M, Decreased 11.05%. In the fiscal year ending Dec 31, 2024, Intra-Cellular Therapies had annual revenue of 680.85M with 46.62% growth.
Revenue (ttm)
680.64M
Revenue Growth
46.62%
P/S Ratio
20.63
Revenue/Employee
$791,688
Employees
860
Market Cap
$14.05B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
680.85M216.48M+46.62%
Dec 31, 2023
464.37M215.24M+86.40%
Dec 31, 2022
249.13M167.42M+204.91%
Dec 31, 2021
81.71M59.18M+262.65%
Dec 31, 2020
22.53M22.47M+37,071.49%
Dec 31, 2019
60.61K+∞%
Dec 31, 2018
0.00-245.84K-100.00%
Dec 31, 2017
245.84K-84.86K-25.66%
Dec 31, 2016
330.70K239.34K+261.96%
Dec 31, 2015
91.36K-485.94K-84.17%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis